{"url":"https://lda.gov/api/v1/filings/48fe7c81-f956-47fb-9d8e-aebe387bef78/","filing_uuid":"48fe7c81-f956-47fb-9d8e-aebe387bef78","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/48fe7c81-f956-47fb-9d8e-aebe387bef78/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"John Aguilar","dt_posted":"2026-04-16T10:58:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20 F St NW","registrant_address_2":"Suite 600","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401106576,"url":"https://lda.gov/api/v1/registrants/401106576/","house_registrant_id":45596,"name":"ALLIANCE FOR REGENERATIVE MEDICINE","description":null,"address_1":"20 F St NW","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN AGUILAR","contact_telephone":"+1 202-344-4149","dt_updated":"2026-07-22T11:41:31.159263-04:00"},"client":{"id":51347,"url":"https://lda.gov/api/v1/clients/51347/","client_id":51347,"name":"ALLIANCE FOR REGENERATIVE MEDICINE","general_description":"Advocacy organization supporting advances in regenerative medicine.","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocate on issues related to regulation of, access to, and reimbursement for regenerative medicine companies and products. Value-based payment legislation and related CMS regulations. FDA appropriations and staffing. Biologics regulation. Prescription Drug User Fee Act (PDUFA). Medicaid. Medicare. Accelerating Kids Access to Care Act (S. 752 / H.R.1509). Mikaela Naylon Give Kids a Chance Act (S. 932 / H.R. 1262). Rare Pediatric Disease Priority Review Vouchers. Bipartisan Health Care Act (S. 891). MVP Act (S.1637). NIH appropriations. HHS oversight. HHS staffing and OPM issues. Medical research. Pharmaceutical tariffs. Biotechnology manufacturing. Newborn screening. FDA oversight.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152687,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"AGUILAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}